BioPharmSignal logoBioPharmSignal

Biotech News

Bionano Symposium 2026 Concluded with 9 Speakers Describing the Breadth of Bionano Solutions and Their Potential for Use on a Large Scale

BioNano Genomics (BNGO)BioNano GenomicsCompany update

SAN DIEGO, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from the fourth and final day of Symposium 2026. Day 4 featured updates from some of the most advanced and high-volume cytogenetics and molecular pathology laboratories in the United

Related news

BNGOBioNano Genomics2026-06-11 12:00 EST

Bionano Announces Multiple Publications in 2026 Describing Unique Utility of OGM in Studies of Reproductive Health and Prenatal Genetic Disorders

BNGOBioNano Genomics2026-05-05 12:00 EST

Bionano Announces a 56% Increase in Publications Describing the Utility of OGM in Rare Diseases in Q1 2026 vs Q1 2025

View all latest news

BioNano Genomics

Genome Analysis Platform Bionano provides optical genome mapping systems and software for identifying structural variants and interpreting genomic data. Saphyr and OGM The Saphyr platform images ultra-high-molecular-weight DNA to detect large genomic changes that can be missed by conventional cytogenetics or short-read sequencing. VIA...

Recent company news

BNGOBioNano Genomics2026-08-24 12:00 EST

Bionano to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

BNGOBioNano Genomics2026-08-10 20:05 EST

Bionano Reports Second Quarter 2026 Results and Provides a Business Update

BNGOBioNano Genomics2026-07-27 20:05 EST

Bionano to Report Second Quarter 2026 Financial Results and Host a Conference Call Webcast on August 10, 2026

BNGOBioNano Genomics2026-06-24 12:30 EST

Bionano Announces Hiring of Chief Scientific Officer

BNGOBioNano Genomics2026-06-18 12:00 EST

Bionano Announces 67% Year-Over-Year Growth in Studies Featuring Optical Genome Mapping at ESHG 2026, Reflecting Expanding Global Adoption

Stock data

Close
1.20 USD
Market cap
14.46M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States